Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy.
Sungyong YouMinhyung KimXen Ping HoiYu Cheng LeeLi WangDavid SpetzlerJim AbrahamDan MageePrerna JainMatthew D GalskyKeith Syson ChanDan TheodorescuPublished in: Journal of the National Cancer Institute (2022)
These findings implicate DDR1 and DDR2 driven signature scores in predicting ICT response.